Archive for the ‘Prostate / Prostate Cancer’ Category
Friday, July 11th, 2008
Deaths due to the four most common cancers - lung, colorectal, prostate, and breast - have dropped substantially in the United States from 1993 to 2001 in working-aged individuals. However, not all Americans are equally likely to benefit from those gains. A study published in the July 8 online issue ...
Posted in Prostate / Prostate Cancer | No Comments »
Wednesday, July 2nd, 2008
"Personal Factors Affecting African-American Men's Prostate Cancer Screening Behavior" (.pdf), Journal of the National Medical Association: The study seeks to identify the personal factors that affect black men's decisions to undergo prostate cancer screenings. Black men have the highest prostate cancer rate of any other racial or ethnic group. For ...
Posted in Prostate / Prostate Cancer | No Comments »
Friday, June 27th, 2008
UroToday.com - In the online version of Urology, The group of Dr. Ashutosh Tewari at Cornell University review outcomes comparisons of open (RRP), laparoscopic (LRP), and robotic assisted (RALP). They reviewed only studies with a sample size of 40 or more patients. Regarding intraoperative results, blood loss, operative time, ...
Posted in Prostate / Prostate Cancer | No Comments »
Friday, June 27th, 2008
ORLANDO, FL (UroToday.com) - Blood loss in radical prostatectomies has been an issue for a long time. New operative techniques led to an optimization regarding not only nerve sparing but also blood sparing attempts. These investigators prospectively studied the influence of the training level of the assisting doctor regarding blood ...
Posted in Prostate / Prostate Cancer | No Comments »
Friday, June 20th, 2008
ORLANDO, FL (UroToday.com) - Dr. Kirsten Greene presented the PSA guidelines. The 2008 guidelines are an update from 2000. They performed a comprehensive literature review, had panel members review the articles then review them again under panel peer review. The consensus opinion is presently under final review. She presented the ...
Posted in Prostate / Prostate Cancer | No Comments »
Wednesday, June 18th, 2008
In Newsweek, Peter Wehrwein, editor, and Anthony Komaroff, editor-in-chief of the Harvard Health Letter, examine racial disparities in breast and prostate cancer outcomes. Black men in the U.S. have the highest prostate cancer rate in the world and are twice as likely as white men to die from the disease. ...
Posted in Prostate / Prostate Cancer | No Comments »
Wednesday, June 18th, 2008
Men treated for prostate cancer have high levels of psychological distress and many suffer ongoing sexual dysfunction and lower urinary tract symptoms, according to a survey of men in England designed to explore their supportive care needs. Prostate cancer is the commonest solid cancer in men, accounting for one in ...
Posted in Prostate / Prostate Cancer | No Comments »
Saturday, June 14th, 2008
UroToday.com - Currently, there is no conclusive evidence that screening based on serum prostate-specific antigen tests decreases prostate-cancer mortality. On one hand, the decline in prostate-cancer mortality in some countries coincided with the introduction of PSA serum examination and consequently the higher uptake of prostate cancer screening. On the other ...
Posted in Prostate / Prostate Cancer | No Comments »
Saturday, June 14th, 2008
UroToday.com - According to a report by Dr. Magheli and colleagues at The Johns Hopkins University, a propensity score matched analysis indicates that a higher body mass index (BMI) is associated with adverse pathologic outcomes and biochemical recurrence after radical prostatectomy. The paper appears in the online version of ...
Posted in Prostate / Prostate Cancer | No Comments »
Saturday, June 14th, 2008
UroToday.com - A group from the UK led by Bridget Candy report a meta-analysis in the BJU International on phosphodiesterase type 5 inhibitors (PDE5i) for the treatment of erectile dysfunction (ED) secondary to treatments for prostate cancer (CaP). Only randomized controlled trials were included and outcomes using validated scales such ...
Posted in Prostate / Prostate Cancer | No Comments »
Saturday, June 14th, 2008
ORLANDO, FL (UroToday.com) - Given significant morbidity and cost of prostate cancer treatment, overtreatment of the disease is a significant public health concern. Watchful waiting and active surveillance protocols are being implemented more frequently and are becoming a widely accepted management option both for patients diagnosed with low risk disease ...
Posted in Prostate / Prostate Cancer | No Comments »
Wednesday, June 11th, 2008
ORLANDO, FL (UroToday.com) - Are all Stage IV prostate cancer (CaP) patients the same? Individuals with distant metastases, regional lymphatic spread, and local invasion can all fall into this category. Hsiao and colleagues examined the Stage IV CaP patients in the SEER database. 2,292 T4N0M0, 6,370 TxN1M0, and 20,633 TxNxM1 ...
Posted in Prostate / Prostate Cancer | No Comments »
Wednesday, June 11th, 2008
ORLANDO, FL (UroToday.com) - In conversations, some young urologists who leave fellowship and enter private practice report much lower positive margin rates than seen by their mentors at academic centers. Are these young and relatively inexperienced surgeons really better prostatectomists than their much more experienced and revered mentors? Clearly not! ...
Posted in Prostate / Prostate Cancer | No Comments »
Wednesday, June 11th, 2008
ORLANDO, FL (UroToday.com) - Banez and colleagues demonstrate a relationship in biochemical recurrence following RRP with the patient's lipid profile. Investigators found that elevated serum cholesterol and elevated serum LDL were independent risk factors for biochemical failure. This study begs the question of whether improvement of the lipid profile reduces ...
Posted in Prostate / Prostate Cancer | No Comments »
Saturday, June 7th, 2008
ORLANDO, FL (UroToday.com) - Simon Kim and colleagues examined outcomes for low risk prostate cancer patients (PSA The outcomes were impressive. 10 years after radical prostatectomy, PSA-free survival and prostate cancer specific survival were 94.5% and 99.8%, respectively. Only 3 patients (0.35%) died of prostate cancer in this group. Should ...
Posted in Prostate / Prostate Cancer | No Comments »
